Introduction
Patients with terminal deletion of the long arm of chromosome 10 present with phenotypic manifestations, including facial dysmorphisms, postnatal growth retardation, developmental delay, mental retardation, digital anomalies, cardiac defects, and genitourinary defects. 1, 2 It is an uncommon chromosomal disorder, with most terminal deletions starting at breakpoints in bands 10q25 or 10q26. In contrast to these terminal deletions, interstitial deletions within bands 10q25e10q26.3 are extremely rare and only seven cases have been reported. 3 However, it is unknown whether the phenotypes are different from terminal deletions. Here, we report the first reported case with a de novo 10q interstitial deletion, del (10)(q26.1q26.3). In addition to many of the phenotypic anomalies previously described in interstitial 10q cases, our patient presented with cataracts.
It is estimated that there are 1.5 million blind children in the world. 4 Cataract is the main cause of treatable blindness in children. Information on the ocular and systemic characteristics of pediatric cataract syndromes is useful for further systemic screening needs and genetic evaluation.
Case Report
The patient, a 10.5-year-old girl, is the first child of healthy, unrelated parents. She was born spontaneously at 36 weeks with uncomplicated pregnancy. Her birth body weight was 2.25 kg (25 th percentile). She had a triangular and asymmetric face, prominent nasal bridge, hypertelorism, malformed ears, right ear skin tag, simian crease, and bilateral clinodactyly ( Figure 1A and B). Congenital heart disease with ventricular septal defect, patent ductus arteriosus, and severe pulmonary artery hypertension was found soon after birth. Total surgical repair was performed at 7 months. Evoked-response audiometry revealed a left sensorineural hearing impairment (hearing loss: left: 65 dB). Development has shown a global delay. She first sat at 14 months, crawled at 20 months, stood at 24 months, and began walking alone at 29 months of age. Her first meaningful words were spoken at 5 years of age and speech delay has been noted since, limited to a few words. Furthermore, verbal comprehension is limited to common verbal instructions. Growth delay was also noted at 6 months old, her height was 54.8 cm (<3 rd percentile) and her weight was 3.8 kg (<3 rd percentile). Global development assessment at 8 years and 10 months showed a developmental quotient (DQ) of 36. Cranio-cerebral magnetic resonance imaging (MRI) was normal. Renal sonography revealed bilateral kidney hypotrophy with no other urogenital defects. The patient is now 10 years and 5 months old. Her height is 103.5 cm (<3 rd percentile) and her weight is 14.5 kg (<3 rd percentile). Eye examination revealed a cataract on the left side at 7 years of age, which was the reason for the first visit to our hospital. The left retina was normal and there was no strabismus.
Chromosome preparation of peripheral white blood cells was performed, and trypsin-banding Giemsa was applied at 550 band resolution. G-banding analysis revealed that the patient had a karyotype of 46, xx, del (10) (q26.1q26.3) (Figure 2 ). In order to rule out familial translocation, parental blood samples were also analyzed and found to be normal. These results indicated that the chromosomal aberration was de novo in origin. An additional study with fluorescence in situ hybridization (FISH) was performed ( Figure 3) . A single whole-chromosome painting probe specific for chromosome 10 (CPMC-GM10926) was employed to further rule out microtranslocation. The FISH result clearly showed that both the normal chromosome 10 and the deleted chromosome 10 were painted and no other painting signal was detected in other chromosomes, indicating that no other chromosome was involved. Further FISH studies were performed to delineate the 10q26 terminal deletion. A ToTelVysis # 10 subtelomeric probe set (spectrumgreen labeled 10pt, spectrumorange labeled 10qt, and spectrumgreen and spectrumorange labeled 15qt) and biotinylated telomere (TTAGGG)n probe were used to study the 10q26 terminal deletion.
The FISH result of the ToTelVysis # 10 subtelomeric probe set showed that the 10qt subtelomeric probe (green signal) was only presented on one 10qt of chromosome 10 homologs in 50 examined metaphase cells ( Figure 4A ). The FISH result of the biotinylated telomere (TTAGGG)n probe revealed that all telomeric regions had FISH signals (red signal) in the 56 metaphase cells examined ( Figure 4B) . Therefore, the FISH results suggested that this patient had a 10q terminal deletion from 10q26.1 to the subtelomeric region, while the universal telomeric sequences existed on the terminal of del(10q) to stabilize the chromosome end of del(10q). Therefore, we considered that the deletion was interstitial with the karyotype of the patient, designated as 46,XX, del(10)(q26.1q26.3). 5 
Discussion
The existence of a 10q-syndrome was suggested previously by Wulfsberg et al, 6 who reviewed 18 cases of terminal 10q deletions. Despite the variation of symptoms, some features are consistently seen, such as facial dysmorphisms characterized by a broad nasal bridge with beaked or prominent noses, strabismus, malformed and low-set ears, hypertelorism and facial asymmetry. Other common features are growth retardation, psychomotor delay, learning disabilities, cryptorchidism in males, genital defects, and digital anomalies such as clinodactly and syndactly. Table 1 with comparison to our case observations. 2,6,9e21 Clinical manifestations of patients with interstitial deletions involving chromosome bands 10q25.2e10q26.3 are also summarized in Table 1 .
Some, but not all, clinical features frequently associated with terminal 10q have also been reported in patients with interstitial deletions. Psychomotor delay, speech delay, motor delay, and learning disabilities were noted in cases with deletions near 10q26 (30/34 cases or 88%) and with interstitial deletions (5/7 or 71%). In our case, developmental assessment at 8 years and 10 months revealed a moderate delay (DQ of 36). Global delay was noted in both groups. Growth retardation was noted in our case, as the patient's height and weight were <3 rd percentile. Other manifestations, such as prominent nose, broad nasal bridge, large or malformed ears, cryptorchidism, and joint abnormalities were also noted in both interstitial and terminal deletion groups. Facial asymmetry, strabismus, and sensorineural hearing loss were different, however (Table 1) . Facial asymmetry was seen in only two cases (including ours) associated with interstitial deletion, although the number of 10q cases is limited. Patients with 10q deletions at a break site near 10q25 appear to have a higher frequency of severe congenital hearing anomalies, anogenital anomalies, and urinary tract anomalies, than those with a break site at 10q26.
2, 10 Waggoner et al 10 concluded that in patients with break sites at 10q25, 71% (5 out of 7) had congenital hearing disease (CHD). 10 Some patients with terminal deletion of chromosome 10q were found to suffer from sex reversal or ambiguous genitalia. 6, 17 Cryptorchidism has been reported in male patients, in addition to genital anomalies such as small scrotum and penis, 14, 15, 22, 23 while females present with hypoplastic external genitalia. 9, 24 However, there was no external genital anomaly in our case. Strabismus was observed in 18 out of 27 terminal deletion cases (67%), but our patient presented with a cataract on the left side without strabismus. Several defects had been reported to be associated with gene mutations/deletions within 10q, such as ectrodactyly (split hand/split foot malformation) at locus 10q24e10q25. 25 In addition, multiple mutations in the fibroblast growth factor receptor 2 gene (also in this region) have been associated with craniosynostosis syndromes. 26, 27 A multiple gene locus study of 10q reported multiple defects. For example, the ADRB1 gene encoding the b 1 adrenergic receptor may be associated with cardiac defects. 8 The b-tectorin gene, together with a-tectorin gene, encodes the major noncollagenous proteins of the tectorial membrane of the cochlea. Three of the patients, including our case, with interstitial 10q25e26.1 deletions had temporary sensorineural and mild hearing loss (Table  1) , 1 which might be associated with b-tectorin haplo insufficiency. Deletions of ADRA2A, the gene encoding the a 2A adrenergic receptor, might be related to learning disabilities. 8 Curiously, however, cataracts have never been Figure 4 FISH analysis with a subtelomeric probe set and biotinylated telomere probe to study the 10q26 terminal deletion.
(A) The FISH result from a subtelomeric probe set showed that the 10qt subtelomeric probe (green signal) was only presented on one 10qt of chromosome 10 homologs. (B) The biotinylated telomere probe revealed that all telomeric regions have FISH signals (red signal). Therefore, the FISH results suggested that this patient has a deletion of 10q from 10q26.1 to the subtelomeric region, while the universal telomeric sequences exist on the terminal of del(10q). FISH Z fluorescence in situ hybridization. reported in 10q deletion cases. In children with cataracts, the etiology may be inherited, stem from a metabolic disease, or be associated with systemic abnormalities, but in most cases, the etiology is unclear. In older children, cataracts are often related to injuries or ocular inflammation related to juvenile rheumatoid arthritis. However, in our case, there was no trauma history or ocular inflammatory disease. There was also no metabolic disease in our patient. There are many systemic disorders including inherited diseases which are associated with pediatric cataract, including abnormal gene locus at 10q. 28, 29 In 1997, Narahara et al 29 reported that the PAX2 gene associated with optic nerve coloboma-renal disease was linked to 10q25.2, suggesting that the PAX2 gene may play a role in the observed optic defects (such as strabismus or cataract). 29 However, further studies into the genetic role of 10q deletion in the pathogenesis are warranted.
Owing to the small number of patients with interstitial deletions, it is not possible to assess the phenotypic overlap with terminal deletion cases with any certainty. Further investigations are necessary, including molecular cytogenetic determination of the deletion size using BAC clones to elucidate whether the clinical manifestation of interstitial deletions 10(q25.2eq26.3) are associated with the extent of the deletion and whether the phenotypic manifestations differ between interstitial and terminal deletions.
Concerning the study limitations, we still cannot exclude the possibility of there being no causal relationship between the cataract and the 10q deletion. Based on this observation, however, we suggest that evaluation of eye status is still required for any individuals with this genetic condition. It is also important for systemic evaluation and genetic counseling to be undertaken in children with a cataract.
